Macdonald, W.A., Chen, Z., Gras, S., Archbold, J.K., Tynan, F.E., Clements, C.S., Bharadwaj, M., Kjer-Nielsen, L., Saunders, P.M., Wilce, M.C.J., et al.: T cell allorecognition via molecular mimicry. Immunity 2009, 31:897–908.
Macedo, C., Orkis, E.A., Popescu, I., Elinoff, B.D., Zeevi, A., Shapiro, R., Lakkis, F.G., and Metes, D.: Contribution of naive and memory T-cell populations to the human alloimmune response. Am. J. Transplant. 2009, 9:2057–2066.
Opelz, G., and Wujciak, T.: The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study. N. Engl. J. Med. 1994, 330:816–819.
15-31 In MHC-identical grafts, rejection is caused by peptides from other alloantigens bound to graft MHC molecules.
Dierselhuis, M., and Goulmy, E.: The relevance of minor histocompatibility antigens in solid organ transplantation. Curr Opin Organ Transplant. 2009, 14:419–425.
den Haan, J.M., Meadows, L.M., Wang, W., Pool, J., Blokland, E., Bishop, T.L., Reinhardus, C., Shabanowitz, J., Offringa, R., Hunt, D.F., et al.: The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 1998, 279:1054–1057.
Mutis, T., Gillespie, G., Schrama, E., Falkenburg, J.H., Moss, P., and Goulmy, E.: Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat. Med. 1999, 5:839–842.
15-32 There are two ways of presenting alloantigens on the transplanted donor organ to the recipient’s T lymphocytes.
Jiang, S., Herrera, O., and Lechler, R.I.: New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr. Opin. Immunol. 2004, 16:550–557.
Safinia, N., Afzali, B., Atalar, K., Lombardi, G., and Lechler, R.I.: T-cell alloimmunity and chronic allograft dysfunction. Kidney Int. 2010, 78(Suppl 119):S2–S12.
Lakkis, F.G., Arakelov, A., Konieczny, B.T., and Inoue, Y.: Immunologic ignorance of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 2000, 6:686–688.
15-33 Antibodies that react with endothelium cause hyperacute graft rejection.
Griesemer, A., Yamada, K., and Sykes, M.: Xenotransplantation: immunological hurdles and progress toward tolerance. Immunol. Rev. 2014, 258:241–258.